sparfloxacin has been researched along with Bacterial Endocarditides in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blatter, M; Entenza, JM; Glauser, MP; Moreillon, P | 1 |
| Donabedian, SA; Perri, MB; Thal, LA; Vazquez, J; Zervos, MJ | 1 |
2 other study(ies) available for sparfloxacin and Bacterial Endocarditides
| Article | Year |
|---|---|
Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci.
Topics: Animals; Anti-Infective Agents; Ceftriaxone; Endocarditis, Bacterial; Female; Fluoroquinolones; Microbial Sensitivity Tests; Penicillin Resistance; Quinolones; Rats; Rats, Wistar; Streptococcal Infections | 1994 |
Sparfloxacin and clinafloxacin alone or in combination with gentamicin for therapy of experimental ampicillin-resistant enterococcal endocarditis in rabbits.
Topics: Ampicillin Resistance; Animals; Anti-Infective Agents; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Enterococcus faecium; Fluoroquinolones; Gentamicins; Gram-Positive Bacterial Infections; Quinolones; Rabbits; Random Allocation | 1993 |